Key players of the necroptosis pathway RIPK1 and SIRT2 are altered in placenta from preeclampsia and fetal growth restriction

DEVELOPING DIAGNOSTICS AND THERAPEUTICS FOR PREECLAMPSIA: TARGETING A NOVEL PLACENTAL SPECIFIC SFLT-1 VARIANT

Preeclampsia is a dreaded disease of pregnancy, globally responsible for thousands of deaths of mothers and babies. It is caused by a protei..

TARGETING THE TOXINS OF PREECLAMPSIA

Preeclampsia is a severe disease of pregnancy - the placenta releases toxins in to mum's bloodstream that circulate her body and damage her ..

Soluble endoglin in the pathogenesis of preeclampsia: investigation of mechanisms and the development of therapeutics

Preeclampsia is a severe disease of pregnancy. As the pathogenesis is poorly understood, the only treatment is for clinicians to deliver bab..

DEVELOPING MOLECULAR THERAPEUTICS AND DIAGNOSTICS FOR PREGNANCY COMPLICATIONS

Pregnancy complications still causes the death of mothers, and their babies. During this fellowship, we will be developing new treatments an..

Mother and baby communication during early pregnancy, the key to establishing a healthy pregnancy

nan